Colobreathe for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis
Quick answer: Colobreathe is used for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis as part of a polymyxin antibiotic (inhaled dry powder) treatment regimen. Colistimethate sodium dry powder inhalation disrupts bacterial outer membrane of Gram-negative pathogens The specific dosing for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis is determined by your prescriber based on individual factors.
Why is Colobreathe used for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis?
Colobreathe belongs to the Polymyxin antibiotic (inhaled dry powder) class. Colistimethate sodium dry powder inhalation disrupts bacterial outer membrane of Gram-negative pathogens This action makes it useful for treating or managing Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Colobreathe is the right choice for a specific patient depends on the type and severity of Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis
Common adult dosing range: 1,662,500 IU inhaled twice daily. The actual dose for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Colobreathe medicine page.
What to expect
Colobreathe treatment for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Colobreathe is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Polymyxin antibiotic (inhaled dry powder) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Colobreathe
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Colobreathe full prescribing information · All Polymyxin antibiotic (inhaled dry powder) alternatives
Frequently asked questions
How effective is Colobreathe for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis?
Effectiveness varies by individual response, dose, and severity. Colobreathe is one of several treatment options for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis, supported by clinical evidence within the polymyxin antibiotic (inhaled dry powder) class. Discuss expected response with your prescriber.
How long do I need to take Colobreathe for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis?
Treatment duration depends on the nature of Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Colobreathe when used for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Colobreathe for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis?
Yes. Multiple medicines and non-drug options exist for Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Alternatives within the polymyxin antibiotic (inhaled dry powder) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.